GLP-1 Receptor Agonist Initiation Is Associated With Excess Skeletal Muscle Loss in Adults With Diabetes: A Prospective Population-Based MRI Study

ObjectiveTo determine whether glucagon-like peptide 1 receptor agonist (GLP-1 RA) initiation is associated with excess skeletal muscle loss on repeat whole-body MRI. Research Design and MethodsIn the German National Cohort, 58 adults with diabetes who initiated a GLP-1 RA between whole-body MRI examinations 4.6 years apart were matched on sex, age, BMI, and interval to 130 never-exposed controls with diabetes. Deep-learning-segmented tissue volumes were compared within matched sets. ResultsSkeletal muscle volume declined 2.75 percentage points more in initiators (95% CI -4.51 to -0.99; P = 0.003), with 2.54 percentage points greater weight loss (P = 0.021). Adipose tissue differences (-4.8% internal torso, -3.2% subcutaneous) were nonsignificant. ConclusionsIn this first population-based comparison of whole-body MRI before and after GLP-1 RA initiation with matched unexposed controls, initiators lost roughly 60% more muscle. Skeletal muscle loss is a measurable component of GLP-1 RA weight loss in routine care. Article HighlightsO_LIWhy did we undertake this study? Rapid uptake of GLP-1 RAs has outpaced evidence on long-term muscle change during routine treatment. C_LIO_LIWhat is the specific question we wanted to answer? We asked whether GLP-1 RA initiation was associated with excess muscle and fat loss versus matched controls with diabetes. C_LIO_LIWhat did we find? Over 4.6 years, initiators lost roughly 60% more skeletal muscle than matched controls (-2.75 percentage points) alongside greater weight loss. Each additional kilogram lost was accompanied by about 100 mL of additional muscle loss. C_LIO_LIWhat are the implications of our findings? Skeletal muscle loss is a measurable component of GLP-1 RA-associated weight loss in routine care. Muscle mass should be monitored during treatment, and muscle-preservation strategies such as resistance training and adequate protein intake need evaluation. C_LI